Retrospective analysis of 736 implants inserted without antibiotic therapy.

Area of Science:

• Oral Surgery
• Implantology
• Pharmacology

Background:

• Routine antibiotic use in oral implantology is common but lacks robust evidence for routine cases.
• Established protocols exist for antibiotic prophylaxis in specific high-risk patient groups (e.g., endocarditis risk, immunocompromised).
• The necessity and impact of antibiotic therapy on dental implant success rates in otherwise healthy patients require critical evaluation.

Purpose of the Study:

• To retrospectively evaluate the outcomes of dental implant treatment conducted without prophylactic antibiotic administration.
• To assess the success and failure rates of dental implants in patients not receiving routine antibiotic prophylaxis.

Main Methods:

• A retrospective analysis of 437 patients receiving 736 dental implants without prophylactic antibiotics.
• Postoperative anti-inflammatory therapy (nimesulide or Arnica montana) was administered for 3 days.
• Implant healing and success were evaluated at second-stage surgery (4-6 months postoperatively), with failure defined by infection or non-osseointegration.

Main Results:

• The overall implant survival rate was 96.2%.
• This survival rate is comparable to success rates reported in literature that utilized various antibiotic regimens.
• No significant difference in implant survival was observed compared to studies employing antibiotic prophylaxis.

Conclusions:

• The findings suggest that routine antibiotic prophylaxis may not be essential for successful dental implant treatment in non-high-risk patients.
• Clinicians should consider reducing the unnecessary use of antibiotics in oral implantology.
• Further research and critical evaluation are needed to clarify the role of antibiotic prophylaxis in oral surgery.